OOIR: Observatory of International Research

Papers

(The TQCC of American Journal of Respiratory and Critical Care Medicine is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline	1209
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease	480
A Single-Cell Atlas of the Human Healthy Airways	335
Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis	263
Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis	256
Tissue-Specific Immunopathology in Fatal COVID-19	250
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary	235
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes	235
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial	195
Symptoms of Anxiety, Depression, and Peritraumatic Dissociation in Critical Care Clinicians Managing Patients with COVID-19. A Cross-Sectional Study	195
Ventilatory Variables and Mechanical Power in Patients with Acute Respiratory Distress Syndrome	194
Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision	192
Air Pollution, Genetic Factors, and the Risk of Lung Cancer: A Prospective Study in the UK Biobank	188
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele	174
A New Global Definition of Acute Respiratory Distress Syndrome	172
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study	170
Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease	158
Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome	157
Latent Class Analysis Reveals COVID-19–related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids	155
Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline	154
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal	153
Sleep Apnea–Specific Hypoxic Burden, Symptom Subtypes, and Risk of Cardiovascular Events and All-Cause Mortality	151
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study	150
From GOLD 0 to Pre-COPD	143
Inflammatory Endotype–associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis	137

Secretory Cells Dominate Airway CFTR Expression and Function in Human Airway Superficial Epithelia	136
Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU	132
New Physical, Mental, and Cognitive Problems 1 Year after ICU Admission: A Prospective Multicenter Study	126
Effect of Lowering Vt on Mortality in Acute Respiratory Distress Syndrome Varies with Respiratory System Elastance	125
Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phase 3 Clinical	120
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial	120
Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis	117
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension	117
Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia	115
Necroptosis Signaling Promotes Inflammation, Airway Remodeling, and Emphysema in Chronic Obstructive Pulmonary Disease	114
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled T	113
Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement	110
The Epidemiological Importance of Subclinical Tuberculosis. A Critical Reappraisal	110
Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs	108
Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case–Control Study	107
The Sleep Apnea–Specific Pulse-Rate Response Predicts Cardiovascular Morbidity and Mortality	106
Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study	105
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles	104
Using Bayesian Methods to Augment the Interpretation of Critical Care Trials. An Overview of Theory and Example Reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial	101
Mitigating Inequities and Saving Lives with ICU Triage during the COVID-19 Pandemic	99
Lung Ultrasound to Monitor Extremely Preterm Infants and Predict Bronchopulmonary Dysplasia. A Multicenter Longitudinal Cohort Study	99
Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland	98
Air Pollution as a Risk Factor for Incident Chronic Obstructive Pulmonary Disease and Asthma. A 15-Year Population-based Cohort Study	97
Sleep Apnea and COVID-19 Mortality and Hospitalization	96
High Prevalence of Pulmonary Sequelae at 3 Months after Hospital Discharge in Mechanically Ventilated Survivors of COVID-19	96
Multinight Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea	93
A Race-neutral Approach to the Interpretation of Lung Function Measurements	93
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement	93
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances	93
ACE2 Elevation in Severe COVID-19	92
Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline	90
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers	90
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial	88
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward	86
Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes	86
Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline	86
Compliance Phenotypes in Early Acute Respiratory Distress Syndrome before the COVID-19 Pandemic	85
Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures	84
YTHDF1 Regulates Pulmonary Hypertension through Translational Control of MAGED1	81
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis–Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial	80
Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists	80
Episodic Aspiration with Oral Commensals Induces a MyD88-dependent, Pulmonary T-Helper Cell Type 17 Response that Mitigates Susceptibility to Streptococcus pneumoniae	78
Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial	77
Latent Tuberculosis: Two Centuries of Confusion	76
Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease	75
Equitably Allocating Resources during Crises: Racial Differences in Mortality Prediction Models	74
Reconsidering the Utility of Race-Specific Lung Function Prediction Equations	74
Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review	74
Chemokine Receptor 2–targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial	73
Machine Learning for Early Lung Cancer Identification Using Routine Clinical and Laboratory Data	72

Decreased Fatty Acid Oxidation and Altered Lactate Production during Exercise in Patients with Post-acute COVID-19 Syndrome	72
Airspace Macrophages and Monocytes Exist in Transcriptionally Distinct Subsets in Healthy Adults	72
Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study	71
Single-Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell	71
Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study	70
What Is Asthma?	70
Trajectory of Preserved Ratio Impaired Spirometry: Natural History and Long-Term Prognosis	69
Endotypic Mechanisms of Successful Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea	69
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomiz	68
Sustained Coinfections withStaphylococcus aureusandPseudomonas aeruginosain Cystic Fibrosis	67
Peri-intubation Cardiovascular Collapse in Patients Who Are Critically Ill: Insights from the INTUBE Study	67
Effects of Weight Loss on Obstructive Sleep Apnea Severity. Ten-Year Results of the Sleep AHEAD Study	67
Effect of Positive End-Expiratory Pressure and Proning on Ventilation and Perfusion in COVID-19 Acute Respiratory Distress Syndrome	67
Mucus Plugs Persist in Asthma, and Changes in Mucus Plugs Associate with Changes in Airflow over Time	66
Hospital-Free Days: A Pragmatic and Patient-centered Outcome for Trials among Critically and Seriously Ill Patients	66
Early Bacterial Identification among Intubated Patients with COVID-19 or Influenza Pneumonia: A European Multicenter Comparative Clinical Trial	65
Macrophage–NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension	65
Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial	64
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles	64
Validation of Proposed Criteria for Progressive Pulmonary Fibrosis	64
Opioid Use Increases the Risk of Delirium in Critically Ill Adults Independently of Pain	62
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study	62
Extracorporeal Membrane Oxygenation for COVID-19–associated Severe Acute Respiratory Distress Syndrome in Chile: A Nationwide Incidence and Cohort Study	59
Deep Learning–based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography	59
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia	59
Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19	58
Race, Lung Function, and Long-Term Mortality in the National Health and Nutrition Examination Survey III	58
Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis	58
Urinary Leukotriene E₄and Prostaglandin D₂Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study	57
Recurrent Severe Preschool Wheeze: From Prespecified Diagnostic Labels to Underlying Endotypes	57
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement	57
Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19	57
BACES Score for Predicting Mortality in Nontuberculous Mycobacterial Pulmonary Disease	56
Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment	56
Positive Airway Pressure Adherence, Mortality, and Cardiovascular Events in Patients with Sleep Apnea	56
An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline	56
Inhibition of Caspase-1 with Tetracycline Ameliorates Acute Lung Injury	56
Bronchial Thermoplasty Induced Airway Smooth Muscle Reduction and Clinical Response in Severe Asthma. The TASMA Randomized Trial	56
Respiratory Tract Dysbiosis Is Associated with Worse Outcomes in Mechanically Ventilated Patients	55
Effect of Esophageal Pressure–guided Positive End-Expiratory Pressure on Survival from Acute Respiratory Distress Syndrome: A Risk-based and Mechanistic Reanalysis of the EPVent-2 Trial	55
Prevalence and Population-Attributable Risk for Chronic Airflow Obstruction in a Large Multinational Study	55
The Effects of Coexposure to Extremes of Heat and Particulate Air Pollution on Mortality in California: Implications for Climate Change	54
Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non–COVID-19 Critical Illness	54
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment	54
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele	54
An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study)	54
Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome	54
The Bidirectional Gut–Lung Axis in Chronic Obstructive Pulmonary Disease	54
Comprehensive Analysis of Fibroblast Activation Protein Expression in Interstitial Lung Diseases	53
Randomized Clinical Trial of Air Cleaners to Improve Indoor Air Quality and Chronic Obstructive Pulmonary Disease Health: Results of the CLEAN AIR Study	52
Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials	52
Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease	52
Biological Subphenotypes of Acute Respiratory Distress Syndrome Show Prognostic Enrichment in Mechanically Ventilated Patients without Acute Respiratory Distress Syndrome	52
Long-Term Outcomes in ICU Patients with Delirium: A Population-based Cohort Study	52
The Effect of Sleep Apnea on Cardiovascular Events in Different Acute Coronary Syndrome Phenotypes	52
Importance of Early COPD in Young Adults for Development of Clinical COPD. Findings from the Copenhagen General Population Study	52
The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis	52
Airway Sensory Nerve Density Is Increased in Chronic Cough	52
Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ	52
Single-Cell Study of Two Rat Models of Pulmonary Arterial Hypertension Reveals Connections to Human Pathobiology and Drug Repositioning	51
Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial	51
Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review	51
Positive End-Expiratory Pressure, Pleural Pressure, and Regional Compliance during Pronation. An Experimental Study	51
Association of Positive End-Expiratory Pressure and Lung Recruitment Selection Strategies with Mortality in Acute Respiratory Distress Syndrome: A Systematic Review and Network Meta-analysis	51
Multiomics Analysis Reveals Distinct Immunogenomic Features of Lung Cancer with Ground-Glass Opacity	50
Muscle Protein Synthesis after Protein Administration in Critical Illness	50
Serial Measurement of Cell-Cycle Arrest Biomarkers [TIMP-2] · [IGFBP7] and Risk for Progression to Death, Dialysis, or Severe Acute Kidney Injury in Patients with Septic Shock	49
High In-Hospital Mortality Rate in Patients with COVID-19 Receiving Extracorporeal Membrane Oxygenation in Germany: A Critical Analysis	49
COVID-19– versus non–COVID-19–related Acute Respiratory Distress Syndrome: Differences and Similarities	49
Comparative Effectiveness of Protective Ventilation Strategies for Moderate and Severe Acute Respiratory Distress Syndrome. A Network Meta-Analysis	48
Passive Prophylactic Administration with a Single Dose of Anti–Fel d 1 Monoclonal Antibodies REGN1908–1909 in Cat Allergen–induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Cli	48
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension	47
Effects of Inhaled Corticosteroid/Long-Acting β₂-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial	47
Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease	47
A Research Agenda for Precision Medicine in Sepsis and Acute Respiratory Distress Syndrome: An Official American Thoracic Society Research Statement	47
Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis	46
Live-attenuated Vaccines Prevent Respiratory Syncytial Virus–associated Illness in Young Children	46
Impact of Positive Airway Pressure Therapy Adherence on Outcomes in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease	46
Associations of Sleep-disordered Breathing and Insomnia with Incident Hypertension and Diabetes. The Hispanic Community Health Study/Study of Latinos	46
Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial	46

Extracellular Vesicles Protect the Neonatal Lung from Hyperoxic Injury through the Epigenetic and Transcriptomic Reprogramming of Myeloid Cells	46
Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19	45
Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study	45
Coarse Particulate Air Pollution and Daily Mortality: A Global Study in 205 Cities	45
Sepsis and Cancer: An Interplay of Friends and Foes	45
Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma	45
Risks of Mortality and Airflow Limitation in Japanese Individuals with Preserved Ratio Impaired Spirometry	45
Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research Program	44
Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure due to COVID-19: A Matched Control Study	44
Circulating BMP9 Protects the Pulmonary Endothelium during Inflammation-induced Lung Injury in Mice	43
The Association of Aging Biomarkers, Interstitial Lung Abnormalities, and Mortality	43
Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the “Chronic Obstructive Pulmonary Disease–Bronchiectasis Association”	43
The Impact of Insulin Resistance on Loss of Lung Function and Response to Treatment in Asthma	43
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension	43
Targeting the P2Y₁₃ Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma	43
A Phase IIb Randomized Clinical Study of an Anti-α_vβ₆ Monoclonal Antibody in Idiopathic Pulmonary Fibrosis	42
The Many Roles of Cholesterol in Sepsis: A Review	42
Enhancing Recruitment and Retention of Minority Populations for Clinical Research in Pulmonary, Critical Care, and Sleep Medicine: An Official American Thoracic Society Research Statement	42
Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial	42
Saracatinib, a Selective Src Kinase Inhibitor, Blocks Fibrotic Responses in Preclinical Models of Pulmonary Fibrosis	42
High-Flow Nasal Oxygen for Severe Hypoxemia: Oxygenation Response and Outcome in Patients with COVID-19	42
Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory Outcomes	42
Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma	42
Palliative Care Early in the Care Continuum among Patients with Serious Respiratory Illness: An Official ATS/AAHPM/HPNA/SWHPN Policy Statement	41
Association of Electronic Cigarette Use with Respiratory Symptom Development among U.S. Young Adults	41
Treatment of Systemic Sclerosis–associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline	41
Historical Redlining Impacts Contemporary Environmental and Asthma-related Outcomes in Black Adults	41
Chronic Effects of High Fine Particulate Matter Exposure on Lung Cancer in China	41
International Consensus on Antineutrophil Cytoplasm Antibodies Testing in Eosinophilic Granulomatosis with Polyangiitis	41
Detecting Deteriorating Patients in the Hospital: Development and Validation of a Novel Scoring System	41
Long-Term Air Pollution Exposure and COVID-19 Mortality: A Patient-Level Analysis from New York City	41
In Vivo Generation of Lung and Thyroid Tissues from Embryonic Stem Cells Using Blastocyst Complementation	41
Prevalence, Intensity, and Clinical Impact of Dyspnea in Critically Ill Patients Receiving Invasive Ventilation	41
Impulse Dispersion of Aerosols during Singing and Speaking: A Potential COVID-19 Transmission Pathway	41
Diagnostic Accuracy of Endobronchial Optical Coherence Tomography for the Microscopic Diagnosis of Usual Interstitial Pneumonia	41
Association between Availability of Extracorporeal Membrane Oxygenation and Mortality in Patients with COVID-19 Eligible for Extracorporeal Membrane Oxygenation: A Natural Experiment	41
Ivacaftor Reverses Airway Mucus Abnormalities in a Rat Model Harboring a Humanized G551D-CFTR	41
The Bronchial Circulation in COVID-19 Pneumonia	40
Outpatient Respiratory Management of Infants, Children, and Adolescents with Post-Prematurity Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline	40
Hospital-Level Variation in Death for Critically Ill Patients with COVID-19	39
Therapeutic Targeting of the Respiratory Microbiome	39
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study	39
Reverse Trigger Phenotypes in Acute Respiratory Distress Syndrome	39
Fetal Origins of Asthma: A Longitudinal Study from Birth to Age 36 Years	39
Integrated Biomarkers for the Management of Indeterminate Pulmonary Nodules	39
Aerosolization of Mycobacterium tuberculosis by Tidal Breathing	39
Two New Neutrophil Subsets Define a Discriminating Sepsis Signature	39
Lung Recruitment Assessed by Electrical Impedance Tomography (RECRUIT): A Multicenter Study of COVID-19 Acute Respiratory Distress Syndrome	39
Kinetic Changes of Plasma Renin Concentrations Predict Acute Kidney Injury in Cardiac Surgery Patients	39
Imaging the Respiratory Transition at Birth: Unraveling the Complexities of the First Breaths of Life	39
Lung Ultrasound Prediction Model for Acute Respiratory Distress Syndrome: A Multicenter Prospective Observational Study	38
High Pleural Pressure Prevents Alveolar Overdistension and Hemodynamic Collapse in Acute Respiratory Distress Syndrome with Class III Obesity. A Clinical Trial	38
A Randomized Controlled Clinical Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea	38
Small Airway Reduction and Fibrosis Is an Early Pathologic Feature of Idiopathic Pulmonary Fibrosis	38
Association of Differential Mast Cell Activation with Granulocytic Inflammation in Severe Asthma	38
Daily Exposure to Mild Intermittent Hypoxia Reduces Blood Pressure in Male Patients with Obstructive Sleep Apnea and Hypertension	38
Autoimmune Pulmonary Alveolar Proteinosis	37
Characteristics and Mechanisms of a Sphingolipid-associated Childhood Asthma Endotype	37
The Impact of the COVID-19 Pandemic on Exacerbations and Symptoms in Bronchiectasis: A Prospective Study	37
Attributable Mortality of Ventilator-associated Pneumonia Among Patients with COVID-19	37
Biological Mechanisms of COVID-19 Acute Respiratory Distress Syndrome	37
Cryobiopsy for Identification of Usual Interstitial Pneumonia and Other Interstitial Lung Disease Features. Further Lessons from COLDICE, a Prospective Multicenter Clinical Trial	37
Non-REM Apnea and Hypopnea Duration Varies across Population Groups and Physiologic Traits	37
Polyclonality, Shared Strains, and Convergent Evolution in Chronic Cystic Fibrosis Staphylococcus aureus Airway Infection	37
Inflammasome Activation: A Keystone of Proinflammatory Response in Obstructive Sleep Apnea	37
Cardiovascular Benefit of Continuous Positive Airway Pressure in Adults with Coronary Artery Disease and Obstructive Sleep Apnea without Excessive Sleepiness	37
Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis	36
Trikafta Rescues CFTR and Lowers Monocyte P2X7R-induced Inflammasome Activation in Cystic Fibrosis	36
Association between Type of Fluid Received Prior to Enrollment, Type of Admission, and Effect of Balanced Crystalloid in Critically Ill Adults: A Secondary Exploratory Analysis of the BaSICS Clinical	36
Plasticity of Individual Lung Function States from Childhood to Adulthood	36
Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing	36
Ambient Air Pollutant Exposures and COVID-19 Severity and Mortality in a Cohort of Patients with COVID-19 in Southern California	36
Long-term Air Pollution Exposure and Pneumonia-related Mortality in a Large Pooled European Cohort	35
CD38 Mediates Lung Fibrosis by Promoting Alveolar Epithelial Cell Aging	35
Allergen Immunotherapy Enhances Airway Epithelial Antiviral Immunity in Patients with Allergic Asthma (VITAL Study): A Double-Blind Randomized Controlled Trial	35
Bedside Evaluation of Pulmonary Embolism by Saline Contrast Electrical Impedance Tomography Method: A Prospective Observational Study	35
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Associated with COVID-19: An Emulated Target Trial Analysis	35
Inflammation and Coagulation during Critical Illness and Long-Term Cognitive Impairment and Disability	35
Aprepitant for Cough in Lung Cancer. A Randomized Placebo-controlled Trial and Mechanistic Insights	35
Pregnant and Peripartum Women with COVID-19 Have High Survival with Extracorporeal Membrane Oxygenation: An Extracorporeal Life Support Organization Registry Analysis	34
Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease	34
Association between Intermittent Hypoxemia and Severe Bronchopulmonary Dysplasia in Preterm Infants	34
Ambient Air Pollution and Dysanapsis: Associations with Lung Function and Chronic Obstructive Pulmonary Disease in the Canadian Cohort Obstructive Lung Disease Study	34
Beneficial Effects of Noninvasive Ventilation after Extubation in Obese or Overweight Patients: A Post Hoc Analysis of a Randomized Clinical Trial	34
Research Priorities for Patients with Heart Failure and Central Sleep Apnea. An Official American Thoracic Society Research Statement	34
Relative Hypotension and Adverse Kidney-related Outcomes among Critically Ill Patients with Shock. A Multicenter, Prospective Cohort Study	34
Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension	34
Randomized Clinical Study of Temporary Transvenous Phrenic Nerve Stimulation in Difficult-to-Wean Patients	33
Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia–associated Pulmonary Hypertension	33
The Airway Microbiota Modulates Effect of Azithromycin Treatment for Episodes of Recurrent Asthma-like Symptoms in Preschool Children: A Randomized Clinical Trial	33
Noninvasive Ventilation Use in Critically Ill Patients with Acute Asthma Exacerbations	33
A Randomized Clinical Trial Using CoronaVac or BNT162b2 Vaccine as a Third Dose in Adults Vaccinated with Two Doses of CoronaVac	33
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells	33
Development and Initial Validation Analyses of the Living with Idiopathic Pulmonary Fibrosis Questionnaire	32
Effects of a Household Air Pollution Intervention with Liquefied Petroleum Gas on Cardiopulmonary Outcomes in Peru. A Randomized Controlled Trial	32